SARA: a “new” low-frequency MNS antigen (MNS47) provides further evidence of the extreme diversity of the MNS blood group system-Reference-Cited by-同舟云学术

SARA: a “new” low-frequency MNS antigen (MNS47) provides further evidence of the extreme diversity of the MNS blood group system

Published:2014-12-19 Issue:6pt2 Volume:55 Page:1451-1456
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

McBean Rhiannon S.¹,Hyland Catherine A.¹,Hendry Julia L.²,Shabani-Rad Meer-Taher²,Flower Robert L.¹

Affiliation:

1. Research and Development; Australian Red Cross Blood Service; Kelvin Grove Queensland Australia

2. Transfusion Medicine; Calgary Laboratory Services; Calgary Alberta Canada

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12973/fullpdf

Reference23 articles.

1. A new low-frequency red cell antigen, “SARAH”;Stern;Vox Sang,1994

2. ISBT Red Cell Immunogenetics and Blood Group Terminology Working Party Blood Group Terminology http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/blood-group-terminology/

3. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA;Towns;Transfusion,2011

4. SCER and SCAN: two novel high-prevalence antigens in the Scianna blood group system;Flegel;Transfusion,2006

5. Red cell antigens on band 3 and Glycophorin A;Poole;Blood Rev,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system;Transfusion;2024-04-30

2. RBCeq: A robust and scalable algorithm for accurate genetic blood typing;eBioMedicine;2022-02

3. RBCeq: An Integrated Bioinformatics Algorithm Designed to Improve Blood Type Compatibility Testing;2021-01-15

4. Next generation sequencing and blood group genotyping: a narrative review;Annals of Blood;2021-01

5. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation;Transfusion and Apheresis Science;2020-10